Vascular Health Startup Evident Emerges from Stealth with $35 Million in Series A Investment

Evident Vascular has stepped out of stealth mode, armed with a $35M Series A boost. The medtech pioneer, based in San Jose, is developing a cutting-edge intravascular ultrasound platform. With Vensana Capital at the helm of this funding round, the startup is gearing up to accelerate R&D efforts, ramp up operations, and extend its market presence under the leadership of CEO Howard Rosen and CTO Patrick Phillips.